However, treatment with PD-1 antagonists in TB infected individuals is under debate as a recent study in Mtb-infected RM demonstrated that anti-PD-1 treated RM had larger lung granulomas, increased bacterial loads and decreased CD4+ T cell functional responses in the granuloma compared to untreated RM (33). Here, CD4 is linked to medical procedure.